Vertexyn Bio Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Vertexyn Bio General Information

Description

Manufacturer of bio-based raw materials aims to advance engineered biotechnology and promote sustainable development. The company's offerings feature high-value natural bio-based raw materials for pharmaceuticals, daily care, functional foods, animal and plant nutrition, and pesticides, supported by expertise in gene data mining, strain engineering, large-scale fermentation, and product application development, enabling healthier living and greener manufacturing worldwide.

Contact Information

Website
www.vertexynbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building C1-1 15 Sixteen TreeHouses
  • Number 73 Tanmi Road., Jiangbei New Dist
  • Xuzhou, Nanjing 221600
  • China
+86 025
Primary Industry
Biotechnology
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Building C1-1 15 Sixteen TreeHouses
  • Number 73 Tanmi Road., Jiangbei New Dist
  • Xuzhou, Nanjing 221600
  • China
+86 025

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vertexyn Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 11-Nov-2025 Completed Generating Revenue
5. Later Stage VC (Series A1) 03-Jun-2025 Completed Generating Revenue
4. Later Stage VC 11-Feb-2025 Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC 10-Mar-2023 Completed Generating Revenue
1. Early Stage VC 22-Sep-2022 Completed Generating Revenue
To view Vertexyn Bio’s complete valuation and funding history, request access »

Vertexyn Bio Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Vertexyn Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025025324-A1 Method for synthesizing l-glufosinate or salt thereof Inactive 01-Aug-2023

Vertexyn Bio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
GF Securities Investment Bank Minority
CMB International Capital Asset Manager Minority
Guangdong Yigao Zhihui Equity Investment Fund Management Growth/Expansion Minority
Nanjing Meitiansheng Venture Capital Management Growth/Expansion Minority
Chunjia Capital PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Vertexyn Bio FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process